TRICYCLIC COMPOUNDS FOR INHIBITING THE CFTR CHANNEL
申请人:AHMED Mahbub
公开号:US20150336986A1
公开(公告)日:2015-11-26
The present invention provides a compound of formula I or a pharmaceutically acceptable salt thereof; and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
Tricyclic compounds for inhibiting the CFTR channel
申请人:Ahmed Mahbub
公开号:US09359381B2
公开(公告)日:2016-06-07
The present invention provides a compound of formula I or a pharmaceutically acceptable salt thereof; and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
Biocatalytic Thionation of Epoxides for Enantioselective Synthesis of Thiiranes
作者:Ran Ma、Xia Hua、Cheng‐Li He、Hui‐Hui Wang、Zhu‐Xiang Wang、Bao‐Dong Cui、Wen‐Yong Han、Yong‐Zheng Chen、Nan‐Wei Wan
DOI:10.1002/anie.202212589
日期:2022.12.23
A biocatalytic thionation method is presented for the enantioselective synthesis of thiiranes from epoxides by a halohydrin dehalogenase catalyzed kinetic resolution approach using thiocyanate as a sulfur donor. Various chiral thiiranes bearing aryl and alkyl substituents were synthesized in good yields and enantioselectivities by using recombinant Escherichia coli cells expressing the engineered halohydrin
[EN] TRICYCLIC COMPOUNDS FOR INHIBITING THE CFTR CHANNEL<br/>[FR] COMPOSÉS TRICYCLIQUES POUR INHIBER LE CANAL CFTR
申请人:NOVARTIS AG
公开号:WO2014097148A1
公开(公告)日:2014-06-26
The present invention provides a compound of formula I or a pharmaceutically acceptable salt thereof; and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.